STAND. COM. REP. NO. 3520
RE: H.B. No. 2384
Honorable Ronald D. Kouchi
President of the Senate
Twenty-Ninth State Legislature
Regular Session of 2018
State of Hawaii
Your Committee on Judiciary, to which was referred H.B. No. 2384, H.D. 1, entitled:
"A BILL FOR AN ACT RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT,"
begs leave to report as follows:
The purpose and intent of this measure is to amend the Uniform Controlled Substances Act to provide flexibility and clear guidance for practitioners who prescribe, administer, or dispense certain controlled substances for patients undergoing medically managed withdrawal or detoxification treatment.
Your Committee received testimony in support of this measure from the Department of Public Safety, Drug Policy Forum of Hawaii, and O‘ahu County Committee on Legislative Priorities of the Democratic Party of Hawai‘i.
Your Committee finds that this measure will permit registered medical practitioners to prescribe drugs including buprenorphine and naloxone for "medically managed withdrawal", also known as "detoxification treatment" and "maintenance treatment". This measure mirrors federal regulations regarding the ability of qualified practitioners to prescribe controlled substances for use as a medically managed withdrawal treatment subject to specific requirements that also mirror federal law.
Your Committee has amended this measure by:
(1) Making it effective upon approval; and
(2) Making a technical, nonsubstantive amendment for the purposes of clarity and consistency.
As affirmed by the record of votes of the members of your Committee on Judiciary that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 2384, H.D. 1, as amended herein, and recommends that it pass Third Reading in the form attached hereto as H.B. No. 2384, H.D. 1, S.D. 1.
Respectfully submitted on behalf of the members of the Committee on Judiciary,
BRIAN T. TANIGUCHI, Chair